• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计即有毒?羧酰胺型合成大麻素CUMYL-PICA、5F-CUMYL-PICA、AMB-FUBINACA、MDMB-FUBINACA、NNEI和MN-18在高温暴露下热降解产物及氰化物的形成

Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.

作者信息

Kevin Richard C, Kovach Alexander L, Lefever Timothy W, Gamage Thomas F, Wiley Jenny L, McGregor Iain S, Thomas Brian F

机构信息

School of Psychology, The University of Sydney, NSW, 2006, Australia.

RTI International, 3040 Cornwallis Road, Research Triangle Park, NC, 27709, USA.

出版信息

Forensic Toxicol. 2019 Jan;37(1):17-26. doi: 10.1007/s11419-018-0430-0. Epub 2018 Jun 28.

DOI:10.1007/s11419-018-0430-0
PMID:30705707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349387/
Abstract

PURPOSE

The use of novel synthetic cannabinoids as intoxicants continues in spite of associated health risks. These compounds are typically smoked or vaporized, but many synthetic cannabinoids contain thermally labile chemical moieties. This study investigated the thermal stability six carboxamide-type synthetic cannabinoids (CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18) in order to characterise potential user exposure to thermolysis products.

METHODS

Compounds were heated sequentially to 200, 400, 600 and 800 °C using a thermolysis probe, and the resultant thermolysis products were analysed via GC-MS. A secondary analysis quantified thermolytically generated cyanide via LC-MS/MS.

RESULTS

All six synthetic cannabinoids underwent thermal degradation when heated above 400 °C, and released a variety of potentially toxic products, including toluene, naphthalene, and 1-naphthalamine. Compound-specific degradants were tentatively identified together with a general degradative pathway for carboxamide-type synthetic cannabinoids, which proceeds via indole- or indazole-amide formation and subsequent dehydration to an indole- or indazole-carbonitrile. This degradative pathway culminated in the thermolytic liberation of cyanide, in amounts up to 27 μg per mg of starting material.

CONCLUSIONS

People who smoke carboxamide-type synthetic cannabinoids are likely to be exposed to range of potentially toxic thermal degradants, including cyanide. These degradants could have significant health impacts in human users.

摘要

目的

尽管存在健康风险,但新型合成大麻素仍被用作毒品。这些化合物通常通过吸烟或汽化使用,但许多合成大麻素含有热不稳定的化学部分。本研究调查了六种羧酰胺型合成大麻素(CUMYL-PICA、5F-CUMYL-PICA、AMB-FUBINACA、MDMB-FUBINACA、NNEI和MN-18)的热稳定性,以确定使用者接触热解产物的可能性。

方法

使用热解探针将化合物依次加热至200、400、600和800°C,通过气相色谱-质谱联用仪(GC-MS)分析所得热解产物。二次分析通过液相色谱-串联质谱联用仪(LC-MS/MS)对热解产生的氰化物进行定量。

结果

当加热到400°C以上时,所有六种合成大麻素都会发生热降解,并释放出多种潜在有毒产物,包括甲苯、萘和1-萘胺。初步鉴定了化合物特异性降解产物以及羧酰胺型合成大麻素的一般降解途径,该途径通过吲哚或吲唑酰胺的形成以及随后脱水形成吲哚或吲唑腈。这条降解途径最终导致氰化物的热解释放,每毫克起始原料中氰化物含量高达27μg。

结论

吸食羧酰胺型合成大麻素的人可能会接触到一系列潜在有毒的热降解产物,包括氰化物。这些降解产物可能会对使用者的健康产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/8237deb61e69/nihms-978590-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/958629404f2f/nihms-978590-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/f29c48bc430f/nihms-978590-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/8237deb61e69/nihms-978590-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/958629404f2f/nihms-978590-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/f29c48bc430f/nihms-978590-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f41c/6349387/8237deb61e69/nihms-978590-f0003.jpg

相似文献

1
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.设计即有毒?羧酰胺型合成大麻素CUMYL-PICA、5F-CUMYL-PICA、AMB-FUBINACA、MDMB-FUBINACA、NNEI和MN-18在高温暴露下热降解产物及氰化物的形成
Forensic Toxicol. 2019 Jan;37(1):17-26. doi: 10.1007/s11419-018-0430-0. Epub 2018 Jun 28.
2
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.滥用合成大麻素 MMB-和 MDMB-FUBINACA、MN-18、NNEI、CUMYL-PICA 和 5-氟-CUMYL-PICA 的分子和行为药理学特征。
J Pharmacol Exp Ther. 2018 May;365(2):437-446. doi: 10.1124/jpet.117.246983. Epub 2018 Mar 16.
3
Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.2018 年在科威特,使用 GC-MS 和 LC-MS-MS 分析鉴定了被缉获、使用或与死亡相关的合成大麻素。
Forensic Sci Int. 2019 Oct;303:109960. doi: 10.1016/j.forsciint.2019.109960. Epub 2019 Sep 13.
4
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.《受管制物质清单》:将六种合成大麻素(5F-ADB、5F-AMB、5F-APINACA、ADB-FUBINACA、MDMB-CHMICA和MDMB-FUBINACA)临时列入附表一。临时管制令。
Fed Regist. 2017 Apr 10;82(67):17119-24.
5
GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.法庭毒物分析中合成大麻素 5F-MDMB-PICA 和 5F-CUMYL-PICA 的 GC-MS/MS 分析。
Bioanalysis. 2024;16(9):401-413. doi: 10.4155/bio-2023-0185. Epub 2024 Mar 11.
6
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.缬氨酸和叔亮氨酸合成大麻素 5F-AMBICA、5F-AMB、5F-ADB、AMB-FUBINACA、MDMB-FUBINACA、MDMB-CHMICA 及其类似物的药理学。
ACS Chem Neurosci. 2016 Sep 21;7(9):1241-54. doi: 10.1021/acschemneuro.6b00137. Epub 2016 Jul 27.
7
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.《管制物质清单》:将六种合成大麻素(5F-ADB、5F-AMB、5F-APINACA、ADB-FUBINACA、MDMB-CHMICA和MDMB-FUBINACA)临时列入第一类。意向通知。
Fed Regist. 2016 Dec 21;81(245):93595-9.
8
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.合成大麻素CUMYL-PICA和5F-CUMYL-PICA的体外和体内药代动力学及代谢
Forensic Toxicol. 2017;35(2):333-347. doi: 10.1007/s11419-017-0361-1. Epub 2017 Mar 10.
9
Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.使用人肝细胞和 LC-QTOF-MS 分析对 4'Cl-CUMYL-PINACA、4'F-CUMYL-5F-PINACA 和 4'F-CUMYL-5F-PICA 的代谢研究。
Basic Clin Pharmacol Toxicol. 2023 Mar;132(3):263-280. doi: 10.1111/bcpt.13829. Epub 2023 Jan 3.
10
Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.合成大麻素的综合调查:以 5F-APP-PICA 和 AMB-FUBINACA 为模型化合物的代谢行为和效力测试。
Drug Test Anal. 2019 Sep;11(9):1358-1368. doi: 10.1002/dta.2659. Epub 2019 Jul 26.

引用本文的文献

1
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.评估大麻素 CB 受体上合成大麻素受体激动剂的信号转导偏倚。
Pharmacol Res Perspect. 2023 Dec;11(6):e01157. doi: 10.1002/prp2.1157.
2
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism.哌嗪类似物对氟苯哌嗪改变了合成大麻素受体激动剂 AMB-FUBINACA 的生理效应的时间进程,而不改变其辨别刺激、信号传递效应或代谢。
Pharmacol Biochem Behav. 2023 Feb;223:173530. doi: 10.1016/j.pbb.2023.173530. Epub 2023 Feb 18.
3

本文引用的文献

1
Metabolism study for CUMYL-4CN-BINACA in human hepatocytes and authentic urine specimens: Free cyanide is formed during the main metabolic pathway.CUMYL-4CN-BINACA在人肝细胞和真实尿液样本中的代谢研究:在主要代谢途径中会形成游离氰化物。
Drug Test Anal. 2018 Mar 25. doi: 10.1002/dta.2373.
2
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.滥用合成大麻素 MMB-和 MDMB-FUBINACA、MN-18、NNEI、CUMYL-PICA 和 5-氟-CUMYL-PICA 的分子和行为药理学特征。
J Pharmacol Exp Ther. 2018 May;365(2):437-446. doi: 10.1124/jpet.117.246983. Epub 2018 Mar 16.
3
Characterisation of AMB-FUBINACA metabolism and CB-mediated activity of its acid metabolite.
AMB-FUBINACA 代谢特征及其酸代谢物的 CB 介导活性。
Forensic Toxicol. 2023 Jan;41(1):114-125. doi: 10.1007/s11419-022-00649-3. Epub 2022 Oct 28.
4
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.合成大麻素受体激动剂(包括AMB-FUBINACA、CUMYL-PINACA、PB-22和XLR-11)的脱靶药理学分析。
Front Psychiatry. 2022 Dec 15;13:1048836. doi: 10.3389/fpsyt.2022.1048836. eCollection 2022.
5
The Spicy Story of Cannabimimetic Indoles.具有刺激性的大麻素吲哚类化合物的故事。
Molecules. 2021 Oct 14;26(20):6190. doi: 10.3390/molecules26206190.
6
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.合成大麻素ADB-FUBINACA和AMB-FUBINACA概述:临床、分析及法医方面的影响
Pharmaceuticals (Basel). 2021 Feb 25;14(3):186. doi: 10.3390/ph14030186.
7
Interpol review of controlled substances 2016-2019.国际刑警组织2016 - 2019年受管制物质审查
Forensic Sci Int Synerg. 2020 May 24;2:608-669. doi: 10.1016/j.fsisyn.2020.01.019. eCollection 2020.
8
Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.四种吲唑-3-甲酰胺型合成大麻素受体激动剂的对映体特异性合成、手性拆分及生物活性及其在缉获毒品样品中的检测
Front Chem. 2019 May 16;7:321. doi: 10.3389/fchem.2019.00321. eCollection 2019.
9
Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.合成大麻素羟基戊基代谢物在人源大麻素受体上保持效力。
J Pharmacol Exp Ther. 2019 Mar;368(3):414-422. doi: 10.1124/jpet.118.254425. Epub 2018 Dec 14.
Qualitative Analysis and Detection of the Pyrolytic Products of JWH-018 and 11 Additional Synthetic Cannabinoids in the Presence of Common Herbal Smoking Substrates.
在常见草药吸烟基质存在的情况下,对JWH-018及另外11种合成大麻素的热解产物进行定性分析和检测。
J Anal Toxicol. 2017 Jul 1;41(6):551-558. doi: 10.1093/jat/bkx039.
4
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice.吸食合成大麻素:一种用于小鼠电子烟使用的新型临床前模型。
Subst Abuse. 2017 Apr 7;11:1178221817701739. doi: 10.1177/1178221817701739. eCollection 2017.
5
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.合成大麻素的热解降解:化学暴露与药理后果
J Pharmacol Exp Ther. 2017 Apr;361(1):162-171. doi: 10.1124/jpet.116.238717. Epub 2017 Jan 13.
6
Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.合成大麻素cumyl-PINACA职业性经皮中毒
Clin Toxicol (Phila). 2017 Mar;55(3):193-195. doi: 10.1080/15563650.2016.1278224. Epub 2017 Jan 13.
7
"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.纽约发生的由合成大麻素 AMB-FUBINACA 引起的“僵尸”疫情。
N Engl J Med. 2017 Jan 19;376(3):235-242. doi: 10.1056/NEJMoa1610300. Epub 2016 Dec 14.
8
Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.摄入合成大麻素后发生的急性横纹肌溶解症。
N Am J Med Sci. 2016 Jun;8(6):256-8. doi: 10.4103/1947-2714.185038.
9
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.缬氨酸和叔亮氨酸合成大麻素 5F-AMBICA、5F-AMB、5F-ADB、AMB-FUBINACA、MDMB-FUBINACA、MDMB-CHMICA 及其类似物的药理学。
ACS Chem Neurosci. 2016 Sep 21;7(9):1241-54. doi: 10.1021/acschemneuro.6b00137. Epub 2016 Jul 27.
10
Synthetic Cannabinoid-Related Illnesses and Deaths.合成大麻素相关疾病与死亡
N Engl J Med. 2015 Jul 9;373(2):103-7. doi: 10.1056/NEJMp1505328.